Chairs: Agnes Lehuen & Andy Hogan
A little bit on the side (#11)
3:30 PM
Optimisation of NKT cell-mediated adjuvant activity for mRNA vaccines (#12)
3:55 PM
The antigen presenting molecule MR1 binds riboflavin catabolites (#13)
4:20 PM
CD1-MR1 2025